Aditxt, Inc. (ADTX) stock rallied over 1.82% intraday to trade at $0.15 a share on NASDAQ. The stock opened with a gain of 5.63% at $0.145 and touched an intraday high of $0.16, rising 4.90% against the last close of $0.143. The stock went to a low of $0.141 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue105.03 Thousands
5Y Sales Change-
Fiscal Year Ends2021-12-30
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Aditxt, Inc. (NASDAQ: ADTX) stock price is $0.15 as of the last check on Friday, July 1. During the trading session, ADTX stock reached the peak price of $0.16 while $0.141 was the lowest point it dropped to.
The NASDAQ listed ADTX is part of Biotechnology industry that operates in the broader Health Care sector. Aditxt, Inc. , a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming.
Dr. Dolly B. Tyan Ph.D.
Sr. VP of Clinical Devel. Â Transplantation
Mr. Amro A. Albanna
Co-Founder, Chairman & CEO
Ms. Corinne D. Pankovcin CPA, CPA, M.B.A.
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.
Co-Founder, Chief Innovation Officer, Sec. & Director
ADTX stock traded closed the last session at $0.146, which is $0.01 or 1.82% lower than its previous close of $0.143. ADTX's current trading price is 17.31% lower than its 52-week high of $3.95 where as its distance from 52-week low of 0.12% is -96.31%.
Number of ADTX employees currently stands at -. ADTX operates from 737 N. Fifth Street, Suite 200, Richmond, VA 23219, United States.
Official Webiste of $ADTX is: https://www.aditxt.com
ADTX stock volume for the day was 5,358,836 shares while in the previous session number of ADTX shares traded was 5,385,900 . The average number of ADTX shares traded daily for last 3 months was 1.82 Million.
The percentage change in ADTX stock occurred in the recent session was 1.82% while the dollar amount for the price change in ADTX stock was $0.01.
In the recent session, the day high for ADTX stock was $0.16 while the low for ADTX stock touched on the day was $0.141.
The market value of ADTX currently stands at 6.39 Million with its latest stock price at $0.15 and 44.58 Million of its shares outstanding.